Reduction in Pulmonary Hypertension and in Airway Resistances by Enoximone (MDL 17,043) in Decompensated COPD
- 1 May 1987
- Vol. 91 (5) , 662-666
- https://doi.org/10.1378/chest.91.5.662
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- New Positive Inotropic Agents in the Treatment of Congestive Heart FailureNew England Journal of Medicine, 1986
- Effects of a new cardiotonic agent, MDL-17,043, on myocardial contractility and left ventricular performance in congestive heart failureAmerican Heart Journal, 1985
- On pulmonary vascular resistance: The need for more precise definitionThe American Journal of Cardiology, 1985
- Positive inotropic and vasodilator effects of MDL 17,043 in patients with reduced left ventricular performanceThe American Journal of Cardiology, 1984
- The acute hemodynamic effects of a new agent, MDL 17,043, in the treatment of congestive heart failure.Circulation, 1983
- Characterization of the Cardiovascular Activities of a New Cardiotonic Agent, MDL 17043 (1,3-Dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one)Journal of Cardiovascular Pharmacology, 1982
- Cardiovascular Properties of a New Cardiotonic AgentJournal of Cardiovascular Pharmacology, 1982
- Some statistical methods useful in circulation research.Circulation Research, 1980
- Hypoxic Pulmonary Vasoconstriction and Infusion of Sodium NitroprussideAnesthesiology, 1979
- Digital computer subroutine for the conversion of oxygen tension into saturation.Journal of Applied Physiology, 1966